查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1446559

動態血壓監測設備市場規模、佔有率、趨勢分析報告：按產品類型、最終用途、地區和細分市場預測，2024-2030 年

Ambulatory Blood Pressure Monitoring Devices Market Size, Share & Trends Analysis Report By Product, By Type, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 60 Pages | 商品交期: 2-10個工作天內

價格

動態血壓監測設備市場成長與趨勢：

Grand View Research, Inc.最新研究顯示，預計2030年全球動態血壓監測設備市場規模將達到18.7億美元，2024年至2030年複合年成長率為8.45%。

加速該市場成長的驅動力包括老年人口的增加、高血壓等慢性病的流行以及全球技術的進步。根據世界衛生組織公佈的統計數據，估計約有11.3億人患有高血壓，每年有760萬人死亡。

此外，在過去的十年中，高血壓已成為出血性中風和冠狀動脈心臟病的主要危險因子。例如，根據世界衛生組織的數據，全球估計有12.8億30歲至79歲的成年人患有高血壓，但42.0%的高血壓成年人不知道自己患有高血壓。我沒有。高血壓不僅是最普遍的疾病，也是心血管疾病、過早死亡和殘疾的主要原因。這也是一筆龐大的經濟負擔。

人口老化也是加速市場成長的因素。根據世界衛生組織2022年10月發布的最新資料，到2030年，全球六分之一的人將超過60歲，到2050年，數字將翻倍。此外，心血管疾病在老年族群中非常普遍。

此外，動態血壓監測（ABPM）設備的技術進步可能會在預測期內提振市場。基於數位技術的行動血壓計的製造正在刺激消費者的需求。新興市場的主要參與者始終致力於開發成本友善、創新且易於使用的設備，預計這將增強市場需求。

動態血壓監測設備市場報告亮點

  • 按產品分類，由於穿戴式技術、應用程式、行動改進、易於存取和易用性等技術不斷進步，設備和配件佔據市場主導地位，2023 年將佔全球收益的 67.5%。
  • 按類型分類，由於血壓袖帶提供的高精度、資料收集的可靠性和使用的彈性，血壓袖帶細分市場在 2023 年以 56.3% 的收益佔有率佔據主導地位。
  • 按最終用途分類，由於住院時間縮短和成本降低，門診手術數量增加，2023 年門診手術中心和診所在 ABPM 設備市場中佔據最大佔有率，為 63.7%。
  • 按地區分類，由於主要企業不斷增加產品推出、整體醫療保健支出不斷增加以及多項監管部門的核准，北美將在 2023 年佔據全球 ABPM 設備市場的主導地位，收益佔有率將達到 39.5%。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章動態血壓監測設備市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 市場機會分析
  • 動態血壓監測設備市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析
  • 動態血壓監測設備市場：區域普及資料
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲 (MEA)

第4章門診血壓監測設備市場：產品評估及趨勢分析

  • 2023年及2030年產品市場佔有率
  • 細分儀表板
  • 全球動態血壓監測設備市場展望（按產品）
  • 2018年至2030年市場規模、預測與趨勢分析

第5章門診血壓監測設備市場：類型估計與趨勢分析

  • 類型市場佔有率，2023 年和 2030 年
  • 細分儀表板
  • 按類型分類的全球動態血壓監測設備市場展望
  • 2018年至2030年市場規模、預測與趨勢分析

第6章動態血壓監測設備市場：最終用途估計與趨勢分析

  • 2023 年及 2030 年最終用途市場佔有率
  • 細分儀表板
  • 按最終用途分類的全球動態血壓監測設備市場前景
  • 2018年至2030年市場規模、預測與趨勢分析

第7章門診血壓監測設備市場：區域估計與趨勢分析

  • 2023 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 全球區域市場概況
  • 2018-2030年市場規模及預測趨勢分析：
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商形勢
    • List of key distributors and channel partners
    • Key customers
    • Key company market share analysis, 2023
    • Omron Healthcare Welch Allyn, Inc.
    • A&D Medical Inc.
    • Microlife Corporation
    • Daray Medical
    • Withings
    • Briggs Healthcare
    • GE Healthcare
    • Rossmax International Ltd.
    • GF Health Products Inc
    • Spacelabs Healthcare Inc.
    • Philips Healthcare
    • Biobeat
    • Spacelabs Healthcare Inc
    • Bosch &Sohn GmbH &Co. KG
    • GE Company,
    • Schiller AG
    • DAIFUKU CO. LTD
Product Code: GVR-4-68040-206-0

Ambulatory Blood Pressure Monitoring Devices Market Growth & Trends:

The global ambulatory blood pressure monitoring devices market size is expected to reach USD 1.87 billion by 2030, expanding at a CAGR of 8.45% from 2024 to 2030, according to a new study by Grand View Research, Inc. The driving factors accelerating the growth of this market include the increasing geriatric population, the prevalence of chronic disorders such as hypertension, and technological advancement worldwide. According to the statistics published by WHO, around 1.13 billion people are likely to suffer from hypertension and causing 7.6 million deaths annually.

In addition, high blood pressure is a major risk factor for hemorrhagic stroke and coronary heart disease in this decade. For instance, as per WHO, an estimated 1.28 billion adults who are aged between 30-79 years globally suffer from hypertension, whereas 42.0% of the adults having hypertension are not aware that they have the condition. Hypertension, besides being the most prevalent, is also the leading cause of cardiovascular disease, premature mortality, and disability. It poses a significant economic burden.

Aging population is another driving factor accelerating the growth of the market. As per the recent WHO statistical data published in October 2022, 1 in 6 people would be over 60 years of age worldwide by 2030 and this number would be doubled by 2050. Moreover, cardiovascular diseases are highly prevalent in the older age population.

Also, technological advancement in ambulatory blood pressure monitoring (ABPM) devices is likely to boost the market over the forecast period. Manufacturing of digital technology-based and mobile blood pressure devices fueling the demand of consumers. Key players in the market consistently focus on the development of cost-friendly, innovative, and easy-to-use devices is likely to strengthen the demand of the market.

Ambulatory Blood Pressure Monitoring Devices Market Report Highlights:

  • Based on the product, instrument & accessories dominated the market and accounted for 67.5 % of global revenue in 2023 owing to constant technological advancements such as improvements in wearable technology, apps, & mobiles, their accessibility, and simplicity in usage
  • Based on the type, the blood pressure cuff segment dominated the market with a revenue share of 56.3% in 2023 due to higher accuracy, reliability of data collection, and flexibility in usage provided by blood cuff
  • Based on the end-use, ambulatory surgical centers & clinics accounted for largest share of 63.7 % of the ABPM devices market in 2023 owing to increasing number of ambulatory surgeries due to short duration of stay and cost savings
  • Based on Based on the region, North America dominated the global ABPM devices market with a revenue share of 39.5 in 2023 owing to increase in product launches by key companies, rising overall healthcare expenditure, and an increase in several regulatory approvals

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Type
    • 1.2.3. End-use
    • 1.2.4. Sales Channel
    • 1.2.5. Regional scope
    • 1.2.6. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in Asia Pacific
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Typeoutlook
    • 2.2.3. End-use outlook
    • 2.2.4. Sales channel outlook
    • 2.2.5. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Ambulatory Blood Pressure Monitoring Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of androgenic alopecia
      • 3.2.1.2. Technological advancements in androgenic alopecia
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Lack of reimbursement policies for androgenic alopecia
    • 3.2.3. Market opportunity analysis
      • 3.2.3.1. Increasing prevalence of chronic diseases
  • 3.3. Ambulatory Blood Pressure Monitoring Devices Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
  • 3.4. Ambulatory Blood Pressure Monitoring Devices Market: Prevalence Data, By Region
    • 3.4.1. North America
      • 3.4.1.1. U.S.
      • 3.4.1.2. Canada
    • 3.4.2. Europe
      • 3.4.2.1. UK
      • 3.4.2.2. Germany
      • 3.4.2.3. France
      • 3.4.2.4. Italy
      • 3.4.2.5. Spain
      • 3.4.2.6. Denmark
      • 3.4.2.7. Sweden
      • 3.4.2.8. Norway
    • 3.4.3. Asia Pacific
      • 3.4.3.1. Japan
      • 3.4.3.2. China
      • 3.4.3.3. India
      • 3.4.3.4. South Korea
      • 3.4.3.5. Australia
      • 3.4.3.6. Thailand
    • 3.4.4. Latin America
      • 3.4.4.1. Brazil
      • 3.4.4.2. Mexico
      • 3.4.4.3. Argentina
    • 3.4.5. Middle East and Africa (MEA)
      • 3.4.5.1. South Africa
      • 3.4.5.2. Saudi Arabia
      • 3.4.5.3. UAE
      • 3.4.5.4. Kuwait

Chapter 4. Ambulatory Blood Pressure Monitoring Devices Market: Product Estimates & Trend Analysis

  • 4.1. Product Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Ambulatory Blood Pressure Monitoring Devices Market by Product Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Ambulatory Blood Pressure Monitors
      • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Instrument & Accessories
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Ambulatory Blood Pressure Monitoring Devices Market: Type Estimates & Trend Analysis

  • 5.1. Type Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Ambulatory Blood Pressure Monitoring Devices Market by Type Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. Blood Pressure Cuffs
      • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Others Type
      • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Ambulatory Blood Pressure Monitoring Devices Market: End-use Estimates & Trend Analysis

  • 6.1. End-use Market Share, 2023 & 2030
  • 6.2. Segment Dashboard
  • 6.3. Global Ambulatory Blood Pressure Monitoring Devices Market by End-use Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.4.1. Hospitals
      • 6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Homecare
      • 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Ambulatory Blood Pressure Monitoring Devices Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.5. North America
    • 7.5.1. U.S.
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
    • 7.5.2. Canada
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
  • 7.6. Europe
    • 7.6.1. UK
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
    • 7.6.2. Germany
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
    • 7.6.3. France
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework/ reimbursement structure
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
    • 7.6.4. Italy
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework/ reimbursement structure
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
    • 7.6.5. Spain
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework/ reimbursement structure
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
    • 7.6.6. Norway
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework/ reimbursement structure
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
    • 7.6.7. Sweden
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Regulatory framework/ reimbursement structure
      • 7.6.7.3. Competitive scenario
      • 7.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
    • 7.6.8. Denmark
      • 7.6.8.1. Key country dynamics
      • 7.6.8.2. Regulatory framework/ reimbursement structure
      • 7.6.8.3. Competitive scenario
      • 7.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
  • 7.7. Asia Pacific
    • 7.7.1. Japan
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
    • 7.7.2. China
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
    • 7.7.3. India
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
    • 7.7.4. Australia
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
    • 7.7.5. South Korea
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Regulatory framework/ reimbursement structure
      • 7.7.5.3. Competitive scenario
      • 7.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
    • 7.7.6. Thailand
      • 7.7.6.1. Key country dynamics
      • 7.7.6.2. Regulatory framework/ reimbursement structure
      • 7.7.6.3. Competitive scenario
      • 7.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Regulatory framework/ reimbursement structure
      • 7.8.1.3. Competitive scenario
      • 7.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
    • 7.8.2. Mexico
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework/ reimbursement structure
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
    • 7.8.3. Argentina
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Regulatory framework/ reimbursement structure
      • 7.8.3.3. Competitive scenario
      • 7.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. Key country dynamics
      • 7.9.1.2. Regulatory framework/ reimbursement structure
      • 7.9.1.3. Competitive scenario
      • 7.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Regulatory framework/ reimbursement structure
      • 7.9.2.3. Competitive scenario
      • 7.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
    • 7.9.3. UAE
      • 7.9.3.1. Key country dynamics
      • 7.9.3.2. Regulatory framework/ reimbursement structure
      • 7.9.3.3. Competitive scenario
      • 7.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
    • 7.9.4. Kuwait
      • 7.9.4.1. Key country dynamics
      • 7.9.4.2. Regulatory framework/ reimbursement structure
      • 7.9.4.3. Competitive scenario
      • 7.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2023
    • 8.3.4. Omron Healthcare Welch Allyn, Inc.
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. A&D Medical Inc.
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Microlife Corporation
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Daray Medical
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Withings
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Briggs Healthcare
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. GE Healthcare
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Rossmax International Ltd.
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. GF Health Products Inc
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. Spacelabs Healthcare Inc.
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Product benchmarking
      • 8.3.13.4. Strategic initiatives
    • 8.3.14. Philips Healthcare
      • 8.3.14.1. Company overview
      • 8.3.14.2. Financial performance
      • 8.3.14.3. Product benchmarking
      • 8.3.14.4. Strategic initiatives
    • 8.3.15. Biobeat
      • 8.3.15.1. Company overview
      • 8.3.15.2. Financial performance
      • 8.3.15.3. Product benchmarking
      • 8.3.15.4. Strategic initiatives
    • 8.3.16. Spacelabs Healthcare Inc
      • 8.3.16.1. Company overview
      • 8.3.16.2. Financial performance
      • 8.3.16.3. Product benchmarking
      • 8.3.16.4. Strategic initiatives
    • 8.3.17. Bosch & Sohn GmbH & Co. KG
      • 8.3.17.1. Company overview
      • 8.3.17.2. Financial performance
      • 8.3.17.3. Product benchmarking
      • 8.3.17.4. Strategic initiatives
    • 8.3.18. GE Company,
      • 8.3.18.1. Company overview
      • 8.3.18.2. Financial performance
      • 8.3.18.3. Product benchmarking
      • 8.3.18.4. Strategic initiatives
    • 8.3.19. Schiller AG
      • 8.3.19.1. Company overview
      • 8.3.19.2. Financial performance
      • 8.3.19.3. Product benchmarking
      • 8.3.19.4. Strategic initiatives
    • 8.3.20. DAIFUKU CO. LTD
      • 8.3.20.1. Company overview
      • 8.3.20.2. Financial performance
      • 8.3.20.3. Product benchmarking
      • 8.3.20.4. Strategic initiative

List of Tables

  • Table 1. List of abbreviation
  • Table 2. North America Ambulatory Blood Pressure Monitoring Devices Market, by country, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Table 3. North America Ambulatory Blood Pressure Monitoring Devices Market, by Product , 2018 - 2030 (USD Million)
  • Table 4. North America Ambulatory Blood Pressure Monitoring Devices Market, by treatment, 2018 - 2030 (USD Million)
  • Table 5. North America Ambulatory Blood Pressure Monitoring Devices Market, by end-use, 2018 - 2030 (USD Million)
  • Table 6. U.S. Ambulatory Blood Pressure Monitoring Devices Market, by Product , 2018 - 2030 (USD Million)
  • Table 7. U.S. Ambulatory Blood Pressure Monitoring Devices Market, by treatment, 2018 - 2030 (USD Million)
  • Table 8. U.S. Ambulatory Blood Pressure Monitoring Devices Market, by end-use, 2018 - 2030 (USD Million)
  • Table 9. Canada Ambulatory Blood Pressure Monitoring Devices Market, by Product , 2018 - 2030 (USD Million)
  • Table 10. Canada Ambulatory Blood Pressure Monitoring Devices Market, by treatment, 2018 - 2030 (USD Million)
  • Table 11. Canada Ambulatory Blood Pressure Monitoring Devices Market, by end-use, 2018 - 2030 (USD Million)
  • Table 12. Europe Ambulatory Blood Pressure Monitoring Devices Market, by country, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Table 13. Europe Ambulatory Blood Pressure Monitoring Devices Market, by Product , 2018 - 2030 (USD Million)
  • Table 14. Europe Ambulatory Blood Pressure Monitoring Devices Market, by treatment, 2018 - 2030 (USD Million)
  • Table 15. Europe Ambulatory Blood Pressure Monitoring Devices Market, by end-use, 2018 - 2030 (USD Million)
  • Table 16. Germany Ambulatory Blood Pressure Monitoring Devices Market, by Product , 2018 - 2030 (USD Million)
  • Table 17. Germany Ambulatory Blood Pressure Monitoring Devices Market, by treatment, 2018 - 2030 (USD Million)
  • Table 18. Germany Ambulatory Blood Pressure Monitoring Devices Market, by end-use, 2018 - 2030 (USD Million)
  • Table 19. UK Ambulatory Blood Pressure Monitoring Devices Market, by Product , 2018 - 2030 (USD Million)
  • Table 20. UK Ambulatory Blood Pressure Monitoring Devices Market, by treatment, 2018 - 2030 (USD Million)
  • Table 21. UK Ambulatory Blood Pressure Monitoring Devices Market, by end-use, 2018 - 2030 (USD Million)
  • Table 22. France Ambulatory Blood Pressure Monitoring Devices Market, by Product , 2018 - 2030 (USD Million)
  • Table 23. France Ambulatory Blood Pressure Monitoring Devices Market, by treatment, 2018 - 2030 (USD Million)
  • Table 24. France Ambulatory Blood Pressure Monitoring Devices Market, by end-use, 2018 - 2030 (USD Million)
  • Table 25. Italy Ambulatory Blood Pressure Monitoring Devices Market, by Product , 2018 - 2030 (USD Million)
  • Table 26. Italy Ambulatory Blood Pressure Monitoring Devices Market, by treatment, 2018 - 2030 (USD Million)
  • Table 27. Italy Ambulatory Blood Pressure Monitoring Devices Market, by end-use, 2018 - 2030 (USD Million)
  • Table 28. Spain Ambulatory Blood Pressure Monitoring Devices Market, by Product , 2018 - 2030 (USD Million)
  • Table 29. Spain Ambulatory Blood Pressure Monitoring Devices Market, by treatment, 2018 - 2030 (USD Million)
  • Table 30. Spain Ambulatory Blood Pressure Monitoring Devices Market, by end-use, 2018 - 2030 (USD Million)
  • Table 31. Denmark Ambulatory Blood Pressure Monitoring Devices Market, by Product , 2018 - 2030 (USD Million)
  • Table 32. Denmark Ambulatory Blood Pressure Monitoring Devices Market, by treatment, 2018 - 2030 (USD Million)
  • Table 33. Denmark Ambulatory Blood Pressure Monitoring Devices Market, by end-use, 2018 - 2030 (USD Million)
  • Table 34. Sweden Ambulatory Blood Pressure Monitoring Devices Market, by Product , 2018 - 2030 (USD Million)
  • Table 35. Sweden Ambulatory Blood Pressure Monitoring Devices Market, by treatment, 2018 - 2030 (USD Million)
  • Table 36. Sweden Ambulatory Blood Pressure Monitoring Devices Market, by end-use, 2018 - 2030 (USD Million)
  • Table 37. Norway Ambulatory Blood Pressure Monitoring Devices Market, by Product , 2018 - 2030 (USD Million)
  • Table 38. Norway Ambulatory Blood Pressure Monitoring Devices Market, by treatment, 2018 - 2030 (USD Million)
  • Table 39. Norway Ambulatory Blood Pressure Monitoring Devices Market, by end-use, 2018 - 2030 (USD Million)
  • Table 40. Asia Pacific Ambulatory Blood Pressure Monitoring Devices Market, by country, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Table 41. Asia Pacific Ambulatory Blood Pressure Monitoring Devices Market, by Product , 2018 - 2030 (USD Million)
  • Table 42. Asia Pacific Ambulatory Blood Pressure Monitoring Devices Market, by treatment, 2018 - 2030 (USD Million)
  • Table 43. Asia Pacific Ambulatory Blood Pressure Monitoring Devices Market, by end-use, 2018 - 2030 (USD Million)
  • Table 44. China Ambulatory Blood Pressure Monitoring Devices Market, by Product , 2018 - 2030 (USD Million)
  • Table 45. China Ambulatory Blood Pressure Monitoring Devices Market, by treatment, 2018 - 2030 (USD Million)
  • Table 46. China Ambulatory Blood Pressure Monitoring Devices Market, by end-use, 2018 - 2030 (USD Million)
  • Table 47. Japan Ambulatory Blood Pressure Monitoring Devices Market, by Product , 2018 - 2030 (USD Million)
  • Table 48. Japan Ambulatory Blood Pressure Monitoring Devices Market, by treatment, 2018 - 2030 (USD Million)
  • Table 49. Japan Ambulatory Blood Pressure Monitoring Devices Market, by end-use, 2018 - 2030 (USD Million)
  • Table 50. India Ambulatory Blood Pressure Monitoring Devices Market, by Product , 2018 - 2030 (USD Million)
  • Table 51. India Ambulatory Blood Pressure Monitoring Devices Market, by treatment, 2018 - 2030 (USD Million)
  • Table 52. India Ambulatory Blood Pressure Monitoring Devices Market, by end-use, 2018 - 2030 (USD Million)
  • Table 53. South Korea Ambulatory Blood Pressure Monitoring Devices Market, by Product , 2018 - 2030 (USD Million)
  • Table 54. South Korea Ambulatory Blood Pressure Monitoring Devices Market, by treatment, 2018 - 2030 (USD Million)
  • Table 55. South Korea Ambulatory Blood Pressure Monitoring Devices Market, by end-use, 2018 - 2030 (USD Million)
  • Table 56. Australia Ambulatory Blood Pressure Monitoring Devices Market, by Product , 2018 - 2030 (USD Million)
  • Table 57. Australia Ambulatory Blood Pressure Monitoring Devices Market, by treatment, 2018 - 2030 (USD Million)
  • Table 58. Australia Ambulatory Blood Pressure Monitoring Devices Market, by end-use, 2018 - 2030 (USD Million)
  • Table 59. Thailand Ambulatory Blood Pressure Monitoring Devices Market, by Product , 2018 - 2030 (USD Million)
  • Table 60. Thailand Ambulatory Blood Pressure Monitoring Devices Market, by treatment, 2018 - 2030 (USD Million)
  • Table 61. Thailand Ambulatory Blood Pressure Monitoring Devices Market, by end-use, 2018 - 2030 (USD Million)
  • Table 62. Latin America Ambulatory Blood Pressure Monitoring Devices Market, by country, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Table 63. Latin America Ambulatory Blood Pressure Monitoring Devices Market, by Product , 2018 - 2030 (USD Million)
  • Table 64. Latin America Ambulatory Blood Pressure Monitoring Devices Market, by treatment, 2018 - 2030 (USD Million)
  • Table 65. Latin America Ambulatory Blood Pressure Monitoring Devices Market, by end-use, 2018 - 2030 (USD Million)
  • Table 66. Brazil Ambulatory Blood Pressure Monitoring Devices Market, by Product , 2018 - 2030 (USD Million)
  • Table 67. Brazil Ambulatory Blood Pressure Monitoring Devices Market, by treatment, 2018 - 2030 (USD Million)
  • Table 68. Brazil Ambulatory Blood Pressure Monitoring Devices Market, by end-use, 2018 - 2030 (USD Million)
  • Table 69. Mexico Ambulatory Blood Pressure Monitoring Devices Market, by Product , 2018 - 2030 (USD Million)
  • Table 70. Mexico Ambulatory Blood Pressure Monitoring Devices Market, by treatment, 2018 - 2030 (USD Million)
  • Table 71. Mexico Ambulatory Blood Pressure Monitoring Devices Market, by end-use, 2018 - 2030 (USD Million)
  • Table 72. Argentina Ambulatory Blood Pressure Monitoring Devices Market, by Product , 2018 - 2030 (USD Million)
  • Table 73. Argentina Ambulatory Blood Pressure Monitoring Devices Market, by treatment, 2018 - 2030 (USD Million)
  • Table 74. Argentina Ambulatory Blood Pressure Monitoring Devices Market, by end-use, 2018 - 2030 (USD Million)
  • Table 75. MEA Ambulatory Blood Pressure Monitoring Devices Market, by country, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Table 76. MEA Ambulatory Blood Pressure Monitoring Devices Market, by Product , 2018 - 2030 (USD Million)
  • Table 77. MEA Ambulatory Blood Pressure Monitoring Devices Market, by treatment, 2018 - 2030 (USD Million)
  • Table 78. MEA Ambulatory Blood Pressure Monitoring Devices Market, by end-use, 2018 - 2030 (USD Million)
  • Table 79. South Africa Ambulatory Blood Pressure Monitoring Devices Market, by Product , 2018 - 2030 (USD Million)
  • Table 80. South Africa Ambulatory Blood Pressure Monitoring Devices Market, by treatment, 2018 - 2030 (USD Million)
  • Table 81. South Africa Ambulatory Blood Pressure Monitoring Devices Market, by end-use, 2018 - 2030 (USD Million)
  • Table 82. Saudi Arabia Ambulatory Blood Pressure Monitoring Devices Market, by Product , 2018 - 2030 (USD Million)
  • Table 83. Saudi Arabia Ambulatory Blood Pressure Monitoring Devices Market, by treatment, 2018 - 2030 (USD Million)
  • Table 84. Saudi Arabia Ambulatory Blood Pressure Monitoring Devices Market, by end-use, 2018 - 2030 (USD Million)
  • Table 85. UAE Ambulatory Blood Pressure Monitoring Devices Market, by Product , 2018 - 2030 (USD Million)
  • Table 86. UAE Ambulatory Blood Pressure Monitoring Devices Market, by treatment, 2018 - 2030 (USD Million)
  • Table 87. UAE Ambulatory Blood Pressure Monitoring Devices Market, by end-use, 2018 - 2030 (USD Million)
  • Table 88. Kuwait Ambulatory Blood Pressure Monitoring Devices Market, by Product , 2018 - 2030 (USD Million)
  • Table 89. Kuwait Ambulatory Blood Pressure Monitoring Devices Market, by treatment, 2018 - 2030 (USD Million)
  • Table 90. Kuwait Ambulatory Blood Pressure Monitoring Devices Market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Ambulatory Blood Pressure Monitoring Devices Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Value chain based sizing & forecasting
  • Fig. 6 QFD modelling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Competitive landscape snapshot
  • Fig. 10 Market dynamics
  • Fig. 11 Prevalence of rheumatoid arthritis in 2022, by WHO regions
  • Fig. 12 Porter's five forces analysis
  • Fig. 13 PESTLE analysis
  • Fig. 14 Ambulatory Blood Pressure Monitoring Devices Market: Products outlook and key takeaways
  • Fig. 15 Ambulatory Blood Pressure Monitoring Devices Market: Product movement analysis
  • Fig. 16 Ambulatory blood pressure monitors market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 17 Instrument & accessories market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 Ambulatory Blood Pressure Monitoring Devices Market: Type outlook and key takeaways
  • Fig. 19 Ambulatory Blood Pressure Monitoring Devices Market: Type movement analysis
  • Fig. 20 Blood Pressure Cuffs market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Others market estimates and forecast, 2018 - 2030, USD Million
  • Fig. 22 Ambulatory Blood Pressure Monitoring Devices Market: End-use outlook and key takeaways
  • Fig. 23 Ambulatory Blood Pressure Monitoring Devices Market: End-use movement analysis
  • Fig. 24 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Ambulatory Surgical Centers & Clinics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Home-care settings market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Provincial marketplace: Key takeaways (1/2)
  • Fig. 28 Provincial marketplace: Key takeaways (2/2)
  • Fig. 29 North America Ambulatory Blood Pressure Monitoring Devices Market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 30 Key country dynamics
  • Fig. 31 U.S. ambulatoryblood pressure monitoring market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 32 Key country dynamics
  • Fig. 33 Canada ambulatoryblood pressure monitoring market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 34 Europe Ambulatory Blood Pressure Monitoring Devices Market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 35 Key country dynamics
  • Fig. 36 UK Ambulatory Blood Pressure Monitoring Devices Market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 37 Key country dynamics
  • Fig. 38 Germany Ambulatory Blood Pressure Monitoring Devices Market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 39 Key country dynamics
  • Fig. 40 France Ambulatory Blood Pressure Monitoring Devices Market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 41 Key country dynamics
  • Fig. 42 Spain Ambulatory Blood Pressure Monitoring Devices Market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 43 Key country dynamics
  • Fig. 44 Italy Ambulatory Blood Pressure Monitoring Devices Market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 45 Key country dynamics
  • Fig. 46 Denmark Ambulatory Blood Pressure Monitoring Devices Market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 47 Key country dynamics
  • Fig. 48 Sweden Ambulatory Blood Pressure Monitoring Devices Market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 49 Key country dynamics
  • Fig. 50 Norway Ambulatory Blood Pressure Monitoring Devices Market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 51 Rest of Europe Ambulatory Blood Pressure Monitoring Devices Market estimates and forecasts, 2018 - 2030, (USD million) (Number of Patients Treated in Thousands)
  • Fig. 52 Asia Pacific ambulatory blood pressure monitoring market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 53 Key country dynamics
  • Fig. 54 Reimbursement scenario
  • Fig. 55 Japan Ambulatory Blood Pressure Monitoring Devices Market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 56 Key country dynamics
  • Fig. 57 Regulatory framework
  • Fig. 58 Reimbursement scenario
  • Fig. 59 China Ambulatory Blood Pressure Monitoring Devices Market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 60 Key country dynamics
  • Fig. 61 Reimbursement scenario
  • Fig. 62 India ambulatory blood pressure monitoring market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 63 Key country dynamics
  • Fig. 64 Australia Ambulatory Blood Pressure Monitoring Devices Market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 65 Key country dynamics
  • Fig. 66 South Korea Ambulatory Blood Pressure Monitoring Devices Market estimates and forecasts, 2018 -2030, (USD million) (Number of Patients Treated in Thousands)
  • Fig. 67 Key country dynamics
  • Fig. 68 Thailand ambulatoryblood pressure monitoring market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 69 Key country dynamics
  • Fig. 70 Malaysia Ambulatory Blood Pressure Monitoring Devices Market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 71 Key country dynamics
  • Fig. 72 Vietnam Ambulatory Blood Pressure Monitoring Devices Market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 73 Key country dynamics
  • Fig. 74 Philippines Ambulatory Blood Pressure Monitoring Devices Market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 75 Rest of Asia Pacific Ambulatory Blood Pressure Monitoring Devices Market estimates and forecasts, 2018 - 2030, (USD million) (Number of Patients Treated in Thousands)
  • Fig. 76 Latin America Ambulatory Blood Pressure Monitoring Devices Market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 77 Key country dynamics
  • Fig. 78 Brazil regulation details
  • Fig. 79 Reimbursement scenario
  • Fig. 80 Brazil Ambulatory Blood Pressure Monitoring Devices Market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 81 Key country dynamics
  • Fig. 82 Argentina pharmaceuticals registration details
  • Fig. 83 Argentina Ambulatory Blood Pressure Monitoring Devices Market estimates and forecasts, 2018 - 2030 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 84 Key country dynamics
  • Fig. 85 Regulatory framework
  • Fig. 86 Reimbursement scenario
  • Fig. 87 Mexico Ambulatory Blood Pressure Monitoring Devices Market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 88 Rest of Latin America Ambulatory Blood Pressure Monitoring Devices Market estimates and forecasts, 2018 - 2030, (USD million) (Number of Patients Treated in Thousands)
  • Fig. 89 MEA Ambulatory Blood Pressure Monitoring Devices Market estimates and forecasts, 2018 - 2030, (USD million)
  • Fig. 90 Key country dynamics
  • Fig. 91 South Africa Ambulatory Blood Pressure Monitoring Devices Market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 92 Key country dynamics
  • Fig. 93 Saudi Arabia Ambulatory Blood Pressure Monitoring Devices Market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 94 Key country dynamics
  • Fig. 95 UAE Ambulatory Blood Pressure Monitoring Devices Market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 96 Key country dynamics
  • Fig. 97 Kuwait Ambulatory Blood Pressure Monitoring Devices Market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 98 Key country dynamics
  • Fig. 99 Turkey Ambulatory Blood Pressure Monitoring Devices Market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 100 Rest of MEA Ambulatory Blood Pressure Monitoring Devices Market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 101 Company market share analysis, 2023
  • Fig. 102 Strategic framework